Marco Pisano

Marco Pisano is the Co-Founder & CEO of Lymphatica Medtech SA, a company developing the first implantable system for chronic lymphedema treatment. With a background in biomedical engineering and extensive experience in research and project management, Marco has been involved in various projects related to developing innovative solutions for lymphatic and cancer tissue engineering. Marco's work has focused on improving the quality of life for individuals suffering from chronic lymphedema, a common side effect of cancer therapies. Marco's dedication to advancing medical technology and their leadership in the field make him a valuable asset in the healthcare industry.